| Dr John C Leadingham, OD | |
|
1330 Carter Ave, Ashland, KY 41101-7544 | |
| (606) 325-9659 | |
| (606) 329-1258 |
| Full Name | Dr John C Leadingham |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 19 Years |
| Location | 1330 Carter Ave, Ashland, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891762514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1659-DT (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Leadingham Eye Care Center - Ashland | 8426229030 | 2 |
News Archive
For parents who have found themselves repeating the same warnings or directions to their toddler over and over to no avail, new research from the University of Colorado at Boulder offers them an answer as to why their toddlers don't listen to their advice: they're just storing it away for later.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai.
TechTeam Global, Inc.,, a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has renewed its contract with American Community Mutual Insurance Company (American Community) to provide a broad range of IT infrastructure outsourcing services.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has initiated a long-term (26-week) toxicology study of CEQ508 – the company's lead drug candidate based on its proprietary tkRNAi technology. This study is designed to enable a Phase II clinical trial slated for 2011. CEQ508 targets beta-catenin, a key oncogene implicated in the formation of colonic polyps and in the progression of polyps to colorectal cancer.
› Verified 4 days ago
| Provider Name | Leadingham Eye Care Center - Ashland |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366723108 PECOS PAC ID: 8426229030 Enrollment ID: O20110912000226 |
News Archive
For parents who have found themselves repeating the same warnings or directions to their toddler over and over to no avail, new research from the University of Colorado at Boulder offers them an answer as to why their toddlers don't listen to their advice: they're just storing it away for later.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai.
TechTeam Global, Inc.,, a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has renewed its contract with American Community Mutual Insurance Company (American Community) to provide a broad range of IT infrastructure outsourcing services.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has initiated a long-term (26-week) toxicology study of CEQ508 – the company's lead drug candidate based on its proprietary tkRNAi technology. This study is designed to enable a Phase II clinical trial slated for 2011. CEQ508 targets beta-catenin, a key oncogene implicated in the formation of colonic polyps and in the progression of polyps to colorectal cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John C Leadingham, OD Po Box 1069, Ashland, KY 41105-1069 Ph: (606) 325-9659 | Dr John C Leadingham, OD 1330 Carter Ave, Ashland, KY 41101-7544 Ph: (606) 325-9659 |
News Archive
For parents who have found themselves repeating the same warnings or directions to their toddler over and over to no avail, new research from the University of Colorado at Boulder offers them an answer as to why their toddlers don't listen to their advice: they're just storing it away for later.
Scientists have used a novel gene therapy to halt the progression of pulmonary hypertension, a form of high blood pressure in the lung blood vessels that is linked to heart failure, according to a study led by Roger J. Hajjar, MD, Professor of Medicine and Director of the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai.
TechTeam Global, Inc.,, a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has renewed its contract with American Community Mutual Insurance Company (American Community) to provide a broad range of IT infrastructure outsourcing services.
Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has initiated a long-term (26-week) toxicology study of CEQ508 – the company's lead drug candidate based on its proprietary tkRNAi technology. This study is designed to enable a Phase II clinical trial slated for 2011. CEQ508 targets beta-catenin, a key oncogene implicated in the formation of colonic polyps and in the progression of polyps to colorectal cancer.
› Verified 4 days ago
Mecca Eye Clinic Optometrist Medicare: Medicare Enrolled Practice Location: 2119 Carter Ave, Ashland, KY 41101 Phone: 606-329-2243 Fax: 606-324-2395 | |
Dr. William E Leadingham, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1330 Carter Ave, Ste 3, Ashland, KY 41101 Phone: 606-329-1258 Fax: 606-329-1258 | |
Dr. Kimberly Kay Epling, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 | |
Socrates Maroudis, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1201 13th St, Ashland, KY 41101 Phone: 606-329-1404 Fax: 606-325-7446 | |
Dr. Aristotle J. Lysandrou, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 451 River Hill Dr, Ashland, KY 41101 Phone: 606-329-2020 Fax: 606-329-2033 | |
Dr. James William Elliott, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 10736 Laurel Ridge Rd, Ashland, KY 41102 Phone: 606-929-9432 Fax: 606-929-9622 | |
Tri-state Ophthalmology Associates Psc Optometrist Medicare: Medicare Enrolled Practice Location: 2841 Lexington Ave, Ashland, KY 41101 Phone: 606-324-2451 Fax: 606-324-7123 |